4-Isopropyl-[1,2,3]thiadiazole-5-carboxylic acid, 95.0%, 5g

1-Hydroxyisoquinoline, 95.0%, 500g

cis-3-(Benzyloxy)cyclobutanamine, 95.0%, 1g

2,3-Dimethyl-n-(2,2,2-trifluoroethyl)aniline, 95%, 1g

3-(2-(((4-(((Hexyloxy)carbonyl)carbamoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoic acid  (Dabigatran Impurity), 97%, 50mg

(2R)-1-(2,4-Difluorophenyl)-2-((tetrahydro-2H-pyran-2-yl)oxy)propan-1-one, 97%, 250mg

N,6-dimethyl-2-morpholin-4-ylpyrimidin-4-amine, 95.0%, 250mg

3-Methoxy-3-methylbutyl acetate, min. 98%, for synthesis, 500 ml, glass packaging

TERT-BUTYL 4-(2-HYDROXY-4-METHYL PHENYLAMINO)PIPERIDINE-1-CARBOXYLATE, 95.0%, 1g

Ethyl oxazole-2-carboxylate, 95.0%, 10g

2',4'-Dichloroacetophenone>98.0%(GC)500g

[(3-Triethoxysilyl)propyl]succinic Anhydride>93.0%(GC)5g

N-p-Aminophenyl-diphenylamine, 97.0%, 1g